Brief: Oryzon To Execute Share Capital Increase For Up To 25 Mln Euros Through Accelerated Book Building

ORYZON Genomics SA

23/04/2025 17:09

April 23 (Reuters) - Oryzon Genomics SA ORY.MC:

LAUNCH OF ACCELERATED BOOK BUILDING OFFER

EXECUTES SHARE CAPITAL INCREASE AGREEMENT FOR UP TO 25 MILLION EUROS THROUGH ISSUE OF ORDINARY SHARES OF 0.05 EUROS EACH

RESULTS OF PRIVATE PLACEMENT PROCEDURE EXPECTED TO BE PUBLISHED ON APRIL 24 BEFORE MARKET OPENING

DISBURSEMENT OF CAPITAL INCREASE EXPECTED ON APRIL 25 BEFORE MARKET OPENING

INTENDS TO USE NET REVENUES OF OPERATION TO STRENGTHEN AND EXPAND CURRENT CLINICAL DEVELOPMENT PLAN FOR AGGRESSIVENESS IN CNS DISEASES

SHARES EXPECTED TO BE DELIVERED TO FINAL INVESTORS ON APRIL 25

INTENDS TO USE NET REVENUES OF OPERATION TO ALSO CONTINUE PREPARING FOR POTENTIAL DUAL LISTING OF ITS SHARES ON NASDAQ

TO CONTINUE TO EVALUATE ADDITIONAL COMMERCIAL TRANSACTIONS, INCLUDING LICENSING AGREEMENTS AND FINANCING ALTERNATIVES TO FULLY FUND ITS PHASE III CLINICAL TRIAL

Source text: ID:nCNM4Nr3zx nFWN3IQ0RE

Further company coverage: ORY.MC

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))